Time | Grand Ballroom 1-2 |
14:00-14:30 | Welcome Refreshment, Foyer |
14:30-16:00 | Oral Abstract Presentation Session (Translational research and case reports) Oral Presentation 1. Cervical tear following Arabin pessary placement for the prevention of preterm birth Oral Presentation 2. Joubert syndrome caused by novel compound heterozygous TMEM237 variants: a case report Oral Presentation 3. Angiogenic factor and anti-angiogenic factor in uterine remodeling of placenta accreta spectrum Oral Presentation 4. E-cadherin in endometrial epithelial cell is a potential endometrial receptivitiy biomarker Oral Presentation 5. Identification of pharmacologically active small molecules that induce spheroid attachment and embryo implantation in vitro and in vivo Oral Presenation 6. Optimizing the non-invasive preimplantation genetic testing in the laboratory |
16:00-17:00 | RCOG Keynote Session RCOG Keynote 1: Why do we need a women's health strategy? RCOG Keynote 2: How to reduce OASIS and its consequences to women? |
17:00-17:30 | Coffee Break, Foyer |
17:30-18:00 | Plenary Lecture 1 (Chair: Prof. Hextan Ngan, Hong Kong) Over-medicalisation in women's health: is it our future? |
18:00-18:30 | Opening Ceremony |
18:30-19:00 | HKCOG Presidential Lecture Cervical Cancer Prevention - What are we up to ? Dr. Karen KL Chan, Hong Kong |
19:00-20:00 | Welcome Reception, Grand Ballroom 4 |
19:45-21:30 | Faculty Dinner, Grand Ballroom 3 |
Time | Grand Ballroom 4 | Grand Ballroom 2-3 | Grand Ballroom 1 |
07:30-08:30 | Light Breakfast, Foyer | ||
08:30-09:00 | Plenary Lecture 2 (Chair: Prof. Tak-Yeung Leung, Hong Kong) Introduction of structured O&G training programme in China |
||
09:00-09:30 | Plenary Lecture 3 (Chair: Prof. Dame Lesley Regan, United Kingdom) The Obstetrician-Gynecologist as Leader |
||
09:40-10:55 | Session 1: Fetal growth restriction (Chairs: Dr. Daniel Chan, Hong Kong; Screening, monitoring and diagnosis of FGR Prevention and treatment for intrauterine growth restriction Oral abstract presentation 7: Impact of immune imbalance on pregnancy outcomes in inflammatory bowel disease |
Session 2: Intrapartum care (Chairs: Dr. Sidney Au-Yeung, Hong Kong; Dr. Meliza Kong, Hong Kong) Induction of labour – what’s new? Intrapartum ultrasound at second stage and beyond Oral presentation 8: Patient satisfaction with informed consent for vaginal birth, a survey-based study Oral presentation 9: Ultrasound assessment of progress in labour: a feasibility study |
Session 3: Endometriosis and uterine disorders (Chairs: Dr. Tomonori Hada, Japan; Endometriosis and infertility : when should surgery be done Evidence-based management of abnormal uterine bleeding in fibroids Updates in management of adenomyosis |
10:55-11:25 | Coffee Break, Foyer | ||
11:25-12:40 | Session 4: Fetal therapy (Chairs: Prof. Mark Kilby, UK; Dr. Kwok-Yin Leung, Hong Kong) Shunting for fetal pleural effusion In utero therapy for fetal arrhythmia Oral presentation 10: Successful transvaginal amniotic shunt in lower urinary tract obstruction (LUTO) |
Session 5: Preinvasive lesions in the lower genital tract (Chairs: Dr. William WH Li, Hong Kong; Dr. Jacqueline HS Lee, Hong Kong) Operationalize cervical cancer elimination in AOFOG Updated HKCOG guidelines for cervical cancer prevention and screening Oral presentation 11: Clinical presentation and long-term outcome of vulvar lichen sclerosus in adult Chinese women Oral presentation 12: Evaluation of the concordance of primary human papilomavirus testing between self-collected and clinician-collected samples |
Session 6: Infertility and assisted reproduction (Chairs: Prof. William SB Yeung, Hong Kong; Use of adjuncts in IVF Fertility Preservation in Female Cancer Patients: Empowering Reproductive Options Oral presentation 13: Transcutaneous electrical nerve stimulation during oocyte retrieval: A randomised controlled trial Oral presentation 14: A randomized controlled trial to compare the live birth rate of the first frozen embryo transfer following ovarian stimulation by the progestin-primed ovarian stimulation protocol versus the antagonist protocol in women with an anticipated high ovarian response undergoing in vitro fertilization |
12:55-13:25 |
|
Lunch Symposium 2 (Sponsored by CMR Surgical) (Chair: Dr. Karen KL Chan, Hong Kong) An evolution in minimally invasive surgery in gynaecology: robotic surgery |
Lunch Symposium 1 (Sponsored by Cornwall HIFU Surgical Centre) (Chairs: Prof. Tak-Yeung Leung, Hong Kong; Dr. Eva CW Cheung, Hong Kong) Pregnancy outcomes after ultrasound-guided high-intensity focused ultrasound (USgHIFU) treatment for uterine fibroids: experience of a single institution |
13:25-13:45 |
|
Hi-Fu Session (Chairs: Dr. Danny TN Leung, Hong Kong; Dr. Vincent Cheung, Hong Kong) Principle of HIFU and clinical application on benign gynecological diseases |
|
13:45-14:45 | Session 7: Fetal anomalies (Chairs: Prof. Christoph Lees, UK; Normal and abnormal fetal cerebral cortical development Logics of fetal cardiology |
Session 8: Cancer genetics (Chairs: Dr. Verda J Hicks, USA; Hereditary cancer syndromes beyond Lynch syndrome and HBOC Endometrial cancer diagnosis beyond WHO classification 2020 |
Session 9: Reproductive endocrinology (Chairs: Prof. Ernest HY Ng, Hong Kong; Menopausal hormone therapy: friend or foe? Management of recurrent miscarriage: how much should we do? |
14:45-15:15 | Coffee Break, Foyer | ||
15:15-16:30 | Session 10: Hypertensive disorder in pregnancy (Chairs: Prof. Wing-Cheong Leung, Hong Kong; Dr. Tsz-Kin Lo, Hong Kong) Use of biomarkers for short term prediction of preeclampsia Safe ride in high tide - hypertensive emergency in pregnancy Oral presentation 15: First-trimester preeclampsia screening: psychological impact on pregnant women throughout pregnancy Oral presentation 16: Single nucleotide polymorphisms and folate related biomarkers concentrations among Chinese preconception women: A genome-wide association study |
Session 11: Pelvic organ prolapse (Chairs: Dr. Symphorosa SC Chan, Hong Kong; Dr. Mandy CH Yu, Hong Kong) Management of advanced stage of pelvic organ prolapse Vaginal mesh use and national registry Ultrasound imaging of synthetic implants in
urogynecology |
Session 12: Endoscopic and reproductive Surgery (Dr. Louis Marcellin, France; Dr. Kwok-Keung Tang, Hong Kong) Modern management of uterine septum vNOTES hysterectomy Contained morcellation |
Plenary Lecture 4 CANCELLED (Chair: Prof. Pisake Lumbiganon, Thailand) Global disruptions as an opportunity in global women's health |
|||
16:40-17:40 | Plenary Lecture 5 (Chair: Prof. Mark Kilby, UK)
|
||
18:30-22:30 | Conferment Ceremony & Gala Dinner |
Time | Grand Ballroom 4 | Grand Ballroom 2-3 | Grand Ballroom 1 |
07:30-08:30 | Light Breakfast, Foyer | ||
08:30-09:00 | Plenary Lecture 6 (Chair: Prof. Andrew Shennan, UK) Implementation of pre-eclampsia screening and prevention in Asia |
||
09:00-09:30 | Plenary Lecture 7 (Chair: Prof. Richard KW Choy, Hong Kong) Improving the clinical utility of prenatal next generation sequencing investigation of the fetus with congenital malformations |
||
09:40-10:55 | Session 13: Critical care in obstetrics (Chairs: Prof. Wing-Hung Tam, Hong Kong; Dr. Lay-Kok Tan, Singapore) Massive transfusion protocol Application of POCT in the management of PPH Oral presentation 17: Obstetric outcomes in Jehovah’s Witnesses: a case-control study over fifteen years in a tertiary teaching hospital Oral presentation 18:Predicting major and severe postpartum haemorrhage during caesarean section for placenta praevia using a simple scoring model |
Session 14: Perinatal genetics (Chairs: Prof. Richard KW Choy, Hong Kong; Dr. Anita Kan, Hong Kong) Implementation of public funded genome
sequencing in evaluation of fetal structural
anomalies Concurrent non-invasive prenatal screening for genetic disorders of heterogenous etiologies: a prospective, multicenter cohort study Invasive prenatal diagnosis, consensus and
controversies |
Session 15: Acute gynaecology (Chairs: Prof. Yutaka Osuga, Japan; Management of extrauterine pregnancy: lessons to learn Caesarean scar pregnancy Oral presentation 19: Association of vitamin D level and miscarriage rate in women presenting with threatened miscarriage to the early pregnancy assessment clinic Oral presentation 20: Women's perspectives on the use of karyotyping of the product of conception in explaining the cause of miscarriages |
10:55-11:15 | Coffee Break, Foyer | ||
11:15-12:30 | Session 16: Preterm birth (Chairs: Dr. Ben CP Chan, Hong Kong; Microbiome and preterm birth Updates on Cervical Cerclage Oral presentation 21: The Utility of First Trimester Cervical Length Measurement by Transvaginal Ultrasound in the Prediction of Preterm Birth - A Systematic Review and Meta-Analysis Oral presentation 22: Longitudinal evaluation of cervical length and shear-wave elastography in women with spontaneous preterm birth |
Session 17: Innovation (Chairs: Dr. Raymond HW Li, Hong Kong; Prof. Liona Poon, Hong Kong) Telemedicine in reproductive health Telehealth – a new door for safe O&G care? Oral presentation 23: Perception among pregnant women and feasibility of telehealth in obstetric services in Hong Kong Oral presentation 24: Smartphone electronic reminder to improve drug adherence during pregnancy: A randomised controlled trial |
Session 18: Free communications (Clinical) (Chairs: Prof. Pisake Lumbiganon, Thailand; Dr. Danny TN Leung, Hong Kong) Oral Presentation 25.Associations between preconception alanine aminotransferase and glycometabolism profile during pregnancy: a community-based retrospective cohort study Oral Presentation 26. The accuracy of self-collected vaginal samples in cervical cancer screening with dual stain p16/Ki-67 Oral Presentation 27.HPV self-sampling for cervical cancer screening in Hong Kong Oral Presentation 29. Parental folate cycle function before pregnancy and spontaneous pregnancy loss: a structural equation modelling approach Oral Presentation 30. Vitamin A and E concentration at early gestation and risk of early-onset atopic dermatitis Oral Presentation 31.Decreased serum soluble programmed cell death ligand-1 level as a potential biomarker for missed miscarriage |
12:30-13:00 |
|
Lunch Symposium 3 (Sponsored by Ferring Pharmaceuticals Ltd.) (Chairs: Prof. Andrew Shennan, UK; The landscape on the ever increasing rate of PPH Cost-effectiveness analysis of Carbetocin in prevention of PPH |
|
13:30-14:30 | Session 19: Multiple pregnancy (Chairs: Dr. Wai-Lam Lau, Hong Kong; Controversies in the management of twin pregnancy Delay interval delivery in pre- and prei-viable multiple pregnancy Oral presentation 32: Prediction of spontaneous preterm delivery in asymptomatic women with twin pregnancies using PAMG-1 and cervical length measurements |
Session 20: Pregnancy and the pelvic floor Childbirth and pelvic floor trauma Obstetric anal sphincter injury Oral presentation 33: An evaluation of the incidence of OASIS in the era of reducing episiotomy rate |
Session 21: Sexual and reproductive health Safe abortion: new updates Recent developments in contraception Oral presentation 34: Advancement or delay of the next menstrual period after levonorgestrel emergency contraception is associated with the cycle day at administration |
14:30-14:45 | Coffee Break, Foyer | ||
14:45-16:00 | Session 22: Postpartum haemorrhage (Chairs: Dr. Teresa WL Ma, Hong Kong; Latest development for placenta accreta spectrum What devices do we have for the management of PPH? Are they fit for purpose? Ultrasound Prediction of Severe Postpartum Haemorrhage in Placenta Accreta Spectrum |
Session 23: Gynaecological malignancies (Chairs: Dr. Soo-Chin Lee, Singapore; Endometrial carcinoma metastic or relapse setting Ovarian sex-cord tumours Oral presentation 35: Circulating tumour cells in gynaecological malignancies Oral presentation 36: Local experience on hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer |
Session 24: Paediatric and adolescent gynaecology (Chairs: Dr. Gang Peng, China, Eliminating abuse, providing opportunities and restoring better health of adolescents Adolescent pregnancy in Hong Kong and across the globe Oral presentation 37: Retrospective review on the management of Herlyn-Werner-Wunderlich syndrome Oral presentation 38: Precocious puberty in a 2 years old girl with sclerosing stromal tumour of ovary: a case report |
16:00-16:15 | Closing Ceremony |
*Program is subject to change without prior notice
HKCOG 35th Anniversary International Conference Secretariat
c/o International Conference Consultants Ltd.
Office Address: Unit C-D, 17/F, Max Share Centre, 373 King's Road, North Point, Hong Kong
Tel: (852) 2559 9973
Fax: (852) 2547 9528
Email: info@hkcog35.org